Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer

NCT01668498 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Ras-wildtype Colorectal Cancer

Interventions

DRUG: Erythromycin
DRUG: Doxycycline

Sponsor

AIO-Studien-gGmbH